CN Patent

CN113754591B — 一种hdac、jak和bet三靶点抑制剂及其制备方法和应用

Assigned to Shandong University · Expires 2024-01-05 · 2y expired

What this patent protects

本发明公开了一种HDAC、JAK和BET三靶点抑制剂及其制备方法和应用。所述的HDAC、JAK和BET三靶点抑制剂，其结构通式为(I)或(II)所示。本发明还提供该类化合物的制备方法以及在制备预防或治疗与HDAC、JAK和BET活性或表达异常相关的疾病的药物中的应用。

USPTO Abstract

本发明公开了一种HDAC、JAK和BET三靶点抑制剂及其制备方法和应用。所述的HDAC、JAK和BET三靶点抑制剂，其结构通式为(I)或(II)所示。本发明还提供该类化合物的制备方法以及在制备预防或治疗与HDAC、JAK和BET活性或表达异常相关的疾病的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN113754591B
Jurisdiction
CN
Classification
—
Expires
2024-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Shandong University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.